View all cases
- Case details
- Status—ActionProcedural applicationCategoryOther procedural
- Parties
- Claimants
- Arbutus Biopharma CorporationOperating co.
- Genevant Sciences GmbHNPE
Representatives- Markus van Gardingen
Respondents- Moderna Belgium S.R.L.Operating co.
- Moderna Denmark ApSOperating co.
- Moderna Portugal Unipessoal LDAOperating co.
- Moderna Poland Sp. z o.o.Operating co.
- Moderna Netherlands B.V.Operating co.
- Moderna Biotech UK LimitedOperating co.
- Moderna Italy S.R.L.Operating co.
- Moderna France SASUOperating co.
- Moderna Biotech Spain SLOperating co.
- Moderna Germany GmbHOperating co.
- Moderna Sweden ABOperating co.
- Moderna Norway ASOperating co.
- ModernaTX, Inc.Operating co.
- Moderna, Inc.Operating co.
- Moderna Switzerland GmbHOperating co.
Representatives- Ruben Laddé
- Joachim Renken
- Division
- The Hague LD
- Judges
- —
- Technology
- ChemistryPharmaceuticals · Biotechnology
- Language
- —
- First decided
- Apr 17, 2025
- EPO Opposition
- Merck Sharp & Dohme CorporationAdmissible2018-04-05
- Moderna Therapeutics, Inc.Admissible2018-04-05
- Merck Sharp & Dohme LLCWithdrawn2018-04-05
- ModernaTX, Inc.Withdrawn2018-04-05
- ModernaTX, Inc.Withdrawn2025-04-29
- Merck Sharp & Dohme (UK) LimitedWithdrawn2025-07-23
- Arrowhouse GmbHAdmissible2025-07-23
- Keltie LLPAdmissible2025-07-23
How this compares
How long the court takes to reach a first decision.
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| The Hague LD | Locked |
At the UPC: Arbutus Biopharma Corporation (12 cases)·Moderna Group (20 cases)
Start 14-day free trialAlready a user? Sign in
Related cases
This dispute contains 6 other proceedings
UPC CFI 617/2025·UPC CFI 607/2025·UPC CFI 191/2025·UPC CFI 192/2025·UPC APP 25212/2025 and 1 more
2 other defendants litigating the same or a related patent
Start a free trial to see how each one ended.
More cases: The Hague LD·2025
Decisions
- 2025-04-17
Summary: The Hague Local Division issued a procedural order rejecting Moderna defendants' requests to extend the deadline for filing preliminary objections and the Statement of Defence under R. 333 RoP, while setting a single consolidated deadline for all Moderna group defendants to file one joint Statement of Defence in the Arbutus/Genevant v. Moderna infringement proceedings (UPC_CFI_191-192/2025).
Show the legal issues (4)
- Deadline for filing preliminary objections and Statement of Defence
- Streamlining procedure for corporate group defendants (R. 333 RoP)
- Service of process on multiple international defendants
- Expeditious proceedings in pharmaceutical infringement
Documents
- 6BAAF9A06DA1B2D4945D0AB2D46F98BB_en.pdf2025-04-17EN